CD40 engagement stimulates IL-12 p70 production by human microglial cells: Basis for Th1 polarization in the CNS

Journal of Neuroimmunology

Volumn 102, Issue 1, 2000, Pages 44-50

  Becher, Burkhard ^a,b   Blain, Manon ^a   Antel, Jack P ^a  

^a DARTMOUTH MEDICAL SCHOOL   (United States)

^b MCGILL UNIVERSITY   (Canada)

Author keywords

CD40; IL 12; Microglia; Multiple sclerosis; Th1 2; TNF

Indexed keywords

GLYCOPROTEIN GP 39; INTERLEUKIN 12;

ANTIGEN EXPRESSION; ARTICLE; CELL DIFFERENTIATION; COCULTURE; CONTROLLED STUDY; CYTOKINE RESPONSIVE ELEMENT; FLOW CYTOMETRY; HELPER CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; MICROGLIA; NORMAL HUMAN; POLARIZATION; PRIORITY JOURNAL; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION;

ANTIGENS, CD40; BRAIN; CD40 LIGAND; CELL POLARITY; HUMANS; INTERFERON TYPE II; INTERLEUKIN-12; LYMPHOCYTE ACTIVATION; MEMBRANE GLYCOPROTEINS; MICROGLIA; T-LYMPHOCYTES; TH1 CELLS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0033992220     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-5728(99)00152-6     Document Type: Article

References (29)

1. Aloisi F., Penna G., Polazzi E., Minghetti L., Adorini L. CD40-CD154 interaction and IFN-gamma are required for IL-12 but not prostaglandin E2 secretion by microglia during antigen presentation to Th1 cells. J. Immunol. 162:1999;1384-1391.
2. Ando D.G., Clayton J., Kono D., Urban J.L., Sercarz E.E. Encephalitogenic T cells in the B10.PL model of experimental allergic encephalomyelitis (EAE) are of the Th-1 lymphokine subtype. Cell. Immunol. 124:1989;132-143.
3. Becher B., Antel J.P. Comparison of phenotypic and functional properties of immediately ex vivo and cultured human adult microglia. Glia. 18:1996;1-10.
4. Becher B., Dodelet V., Fedorowicz V., Antel J.P. Soluble tumor necrosis factor receptor inhibits interleukin 12 production by stimulated human adult microglial cells in vitro. J. Clin. Invest. 98:1996;1539-1543.
5. Becher B., Fedorowicz V., Antel J.P. Regulation of CD14 expression on human adult central nervous system-derived microglia. J. Neurosci. Res. 45:1996;375-381.
6. Becher B., Blain M., Giacomini P.S., Antel J.P. Inhibition of Th1 polarization by soluble TNF receptor is dependent on antigen-presenting cell-derived IL-12. J. Immunol. 162:1999;684-688.
7. Benvenuto R., Paroli M., Buttinelli C., Franco A., Barnaba V., Fieschi C., Balsano F. Tumor necrosis factor-alpha and interferon-gamma synthesis by cerebrospinal fluid-derived T cell clones in multiple sclerosis. Ann. N. Y. Acad. Sci. 650:1992;341-346.
8. Cella M., Scheidegger D., Palmer-Lehmann K., Lane P., Lanzavecchia A., Alber G. Ligation of CD40 on dendritic cells triggers production of high levels of interleukin-12 and enhances T cell stimulatory capacity: T-T help via APC activation. J. Exp. Med. 184:1996;747-752.
9. Cua D.J., Hinton D.R., Stohlman S.A. Self-antigen-induced Th2 responses in experimental allergic encephalomyelitis (EAE)-resistant mice. Th2-mediated suppression of autoimmune disease. J. Immunol. 155:1995;4052-4059.
10. Drulovic J., Mostarica-Stojkovic M., Levic Z., Stojsavljevic N., Pravica V., Mesaros S. Interleukin-12 and tumor necrosis factor-alpha levels in cerebrospinal fluid of multiple sclerosis patients. J. Neurol. Sci. 147:1997;145-150.
11. Gerritse K., Laman J.D., Noelle R.J., Aruffo A., Ledbetter J.A., Boersma W.J., Claassen E. CD40-CD40 ligand interactions in experimental allergic encephalomyelitis and multiple sclerosis. Proc. Natl. Acad. Sci. U.S.A. 93:1996;2499-2504.
12. Howard L.M., Miga A.J., Vanderlugt C.L., Dal Canto M.C., Laman J.D., Noelle R.J., Miller S.D. Mechanisms of immunotherapeutic intervention by anti-CD40L (CD154) antibody in an animal model of multiple sclerosis. J. Clin. Invest. 103:1999;281-290.
13. Kato T., Hakamada R., Yamane H., Nariuchi H. Induction of IL-12 p40 messenger RNA expression and IL-12 production of macrophages via CD40-CD40 ligand interaction. J. Immunol. 156:1996;3932-3938.
14. Koch F., Stanzl U., Jennewein P., Janke K., Heufler C., Kampgen E., Romani N., Schuler G. High level IL-12 production by murine dendritic cells: upregulation via MHC class II and CD40 molecules and downregulation by IL-4 and IL-10. J. Exp. Med. 184:1996;741-746.
15. Kuchroo V.K., Das M.P., Brown J.A., Ranger A.M., Zamvil S.S., Sobel R.A., Weiner H.L., Nabavi N., Glimcher L.H. B7-1 and B7-2 costimulatory molecules activate differentially the Th1/Th2 developmental pathways: application to autoimmune disease therapy. Cell. 80:1995;707-718.
16. Leonard J.P., Waldburger K.E., Goldman S.J. Prevention of experimental autoimmune encephalomyelitis by antibodies against interleukin 12. J. Exp. Med. 181:1995;381-386.
17. Mosmann T.R., Coffman R.L. TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu. Rev. Immunol. 7:1989;145-173.
18. Nicoletti F., Patti F., Cocuzza C., Zaccone P., Nicoletti A., Di Marco R., Reggio A. Elevated serum levels of interleukin-12 in chronic progressive multiple sclerosis. J. Neuroimmunol. 70:1996;87-90.
19. Olsson T. Critical influences of the cytokine orchestration on the outcome of myelin antigen-specific T-cell autoimmunity in experimental autoimmune encephalomyelitis and multiple sclerosis. Immunol. Rev. 144:1995;245-268. Review.
20. Patterson P.H. Cytokines in Alzheimer's disease and multiple sclerosis. Curr. Opin. Neurobiol. 5:1995;642-646.
21. Racke M.K., Bonomo A., Scott D.E., Cannella B., Levine A., Raine C.S., Shevach E.M., Rocken M. Cytokine-induced immune deviation as a therapy for inflammatory autoimmune disease. J. Exp. Med. 180:1994;1961-1966.
22. Renno T., Krakowski M., Piccirillo C., Lin J.Y., Owens T. TNF-alpha expression by resident microglia and infiltrating leukocytes in the central nervous system of mice with experimental allergic encephalomyelitis. Regulation by Th1 cytokines. J. Immunol. 154:1995;944-953.
23. Sedgwick J.D., Ford A.L., Foulcher E., Airriess R. Central nervous system microglial cell activation and proliferation follows direct interaction with tissue-infiltrating T cell blasts. J. Immunol. 160:1998;5320-5330.
24. Segal B.M., Shevach E.M. IL-12 unmasks latent autoimmune disease in resistant mice. J. Exp. Med. 184:1996;771-775.
25. Segal B.M., Dwyer B.K., Shevach E.M. An interleukin (IL)-10/IL-12 immunoregulatory circuit controls susceptibility to autoimmune disease. J. Exp. Med. 187:1998;537-546.
26. Trinchieri G. Interleukin-12: a proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity. Annu. Rev. Immunol. 13:1995;251-276.
27. Windhagen A., Newcombe J., Dangond F., Strand C., Woodroofe M.N., Cuzner M.L., Hafler D.A. Expression of costimulatory molecules B7-1 (CD80), B7-2 (CD86), and interleukin 12 cytokine in multiple sclerosis lesions. J. Exp. Med. 182:1995;1985-1996.
28. Yan S.D., Chen X., Fu J., Chen M., Zhu H., Roher A., Slattery T., Zhao L., Nagashima M., Morser J., Migheli A., Nawroth P., Stern D., Schmidt A.M. RAGE and amyloid-beta peptide neurotoxicity in Alzheimer's disease. Nature. 382:1996;685-691.
29. Yong, V.W., Antel, J.P., 1992. Culture of cells from human brain biopsies. In: Fedoroff, S., Rischardson, A. (Eds.), Protocols for Neural Cell Culture, Plenum, New York, pp. 35-42.